Member Info for gotabesirius

I'm going for an RNS tomorrow or Thursday.....

What price?

Exactly. I'd rather it just builds gradually....

Wait.... Much more news to come here imminently. This is just the start!!

Cathal is presenting at Proactive investor webinar Thursday night.... Watch this space!!

Imagine the newsflow when the world's first coronavirus challenge study is completed and major pharma are fighting each other to get into the lab and quarenteen facility to test their anti virrals and vaccines using HVIVO coronavirus model in London. You couldn't write it for a company this size. It'll be all over the news not just in this country but globally!!!

A world leader in virology and valued at £35m. Its madness! Certainly think a £200m valuation is in play and that's without flu v vaccine

That's a big cherry on a little cake!!

This has more legs than a spider!!!

We could get news on any number of game changing features anytime....

Thanks Bill, was it a feature or just a passing mention? Can't find anything online

A couple of years ago, the hVIVO Scientific team started a project to potentially develop a Coronavirus challenge study model but after a certain amount of work and effort they suspended this project because they didn't see sufficient market demand for a Coronavirus challenge study model. However, in recent weeks, the hVIVO scientific team led by their Chief Scientist Andrew Catchpole have reopened their Coronavirus challenge study project and work files. Given the unfortunate circumstances of Covid-19 now spreading around the world they and I felt that there was an obligation on us to reactivate the project and to do our best to now swiftly and effectively make a Coronavirus challenge study model available to the market as soon as possible.

I'm looking forward to working with the team in the days and weeks ahead to do our best to make the world's first Coronavirus challenge study model available as soon as possible."

The last challenge study announced earlier this month could be worth up to £10-£13m. Once the coronavirus challenge study model is completed how many of the above contracts can we envisage. In conclusion: revenue is about to go through the roof!

Welcome, this company couldn't be more in the eye of this mess. Its a world leader in virology... With a huge data base of studies and expertise which will be vital to support a vaccine or anti viral in the UK and beyond. Its a sad situation but this company will either be sold to government agencies or a major pharmaceutical or will be a multi million pound company in the near future as a result of this disaster....stay safe all and heed the advice (promise me I'm fell informed)

Just a price monitoring extension.. Damn it!

RNS OUT

Possibly, nice to see Cathel off the PR circuit and hopefully flat out in meetings.... It's a reassuring silence which is converse to most AIM companies

Haven't heard this mentioned here... Boris has allocated 10s of millions into R&D in virology. What if the government saw the value in Flu v..... They pay for development in form of a grant

Well said. Same here, and the fact Cathal owns 9%. Only way he'll see his money is if the company is bought out! Worth remembering this imho

To be fair, he did quote the £100m sale price before the coronavirus spread.... So we can maybe forgive him for that.. You could probably double that figure now but I'd take £100m take out any day!

Speaking of the very chap.... Where's he gone?

What in the hell are you lot moaning on about. Its been a very productive board until this morning when a few agenda have appeared. If you think the company will achieve its objectives during a pandemic which is hvivo niche, then hold. If you think its all a bit fishy go chase the market elsewhere and don't complain when the next inevitable wave of downward pressures move back into the market. Markets are running on fumes...